MarraBio

MarraBio

Bacterial protein polymers with crucial biological messages for optimal cell growth. Our solution is a cost-effective, multi-functional material for large-scale cultivation in research, agriculture, or therapy. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€2—4m (Dealroom.co estimates Sep 2023.)
Newcastle upon Tyne England (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Spinout
*

£500k

Seed
Total Funding€600k

Recent News about MarraBio

Edit
More about MarraBioinfo icon
Edit

MarraBio is an innovative biotechnology startup that emerged from Newcastle University in 2023. The company focuses on commercializing proprietary Caf1 proteins, which offer a stable, scalable, and xeno-free (free from animal-derived components) alternative to traditional extracellular matrix proteins and growth factors used in mammalian cell culture. This technology simplifies and accelerates the cell culture process, making it more efficient and cost-effective.

MarraBio's primary clients are researchers and companies in the fields of biotechnology, pharmaceuticals, and cultivated meat production. The company operates in the rapidly growing market of cell culture and tissue engineering, which is crucial for advancements in medical research, drug development, and sustainable food production.

The business model of MarraBio revolves around the development, production, and sale of its proprietary Caf1 proteins. By providing a more user-friendly and stable alternative to existing cell culture reagents, MarraBio aims to reduce costs and improve efficiency for its clients. The company generates revenue through the sale of these proteins and potentially through partnerships and licensing agreements with other biotech firms.

One notable partnership is with Aelius Biotech and CPI, aimed at producing food-grade materials to enhance the production of lab-grown meat. This collaboration seeks to replace expensive reagents currently used in large-scale cell production for cultivated meat. The materials developed by MarraBio must meet food safety regulations and be proven safe for digestion, a process that will be tested by Aelius Biotech using their patented lab model of the human gut system.

In summary, MarraBio is at the forefront of biotechnology innovation, providing essential tools for cell culture that promise to revolutionize various industries by making processes faster, easier, and more cost-effective.

Keywords: Biotechnology, Cell Culture, Caf1 Proteins, Xeno-Free, Scalable, Stable, Cultivated Meat, Food-Grade Materials, Newcastle University, Partnerships.